Indication
Measles-mumps-rubella vaccination
Measles-mumps-rubella vaccination is a preventative immunization indicated for the induction of active immunity against infection by the measles (rubeola) paramyxovirus, mumps rubulavirus, and rubella togavirus. Read more about Measles-mumps-rubella vaccination
7 drugs 3 manufacturers
Drugs that treat it
Common Measles-mumps-rubella vaccination therapies.
M-M-R II VACCINE (measles, mumps, and rubella vaccine live/PF)
PROQUAD (PF) (measles, mumps, rubella, and varicella vaccine live/PF)
M-M-R II (PF) (measles, mumps, and rubella vaccine live/PF)
PRIORIX (PF) (measles, mumps, and rubella vaccine live/PF)
M-M-R II VACCINE (measles, mumps, and rubella vaccine live/PF)
PRIORIX (measles, mumps, and rubella vaccine live/PF)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonMeasles-mumps-rubella vaccination is a preventative immunization indicated for the induction of active immunity against infection by the measles (rubeola) paramyxovirus, mumps rubulavirus, and rubella togavirus.
It is primarily administered across pediatric populations starting at 12 months of age, as well as to susceptible adolescents and adults.
These targeted viral pathogens cause acute systemic infections marked by respiratory spread, high fever, maculopapular rash, and parotitis.
Vaccination prevents severe pathophysiologic complications associated with these diseases, such as viral pneumonia, encephalitis, aseptic meningitis, orchitis, and congenital rubella syndrome resulting from gestational transmission.
- fda.gov
Measles-mumps-rubella vaccination is a preventative immunization indicated for the induction of active immunity against infection by the measles (rubeola) paramyxovirus, mumps rubulavirus, and rubella togavirus It is primarily administered across pediatric populations starting at 12 months of age, as well as to susceptible adolescents and adults
- drugs.com
Measles-mumps-rubella vaccination is a preventative immunization indicated for the induction of active immunity against infection by the measles (rubeola) paramyxovirus, mumps rubulavirus, and rubella togavirus It is primarily administered across pediatric populations starting at 12 months of age, as well as to susceptible adolescents and adults
- nih.gov
Measles-mumps-rubella vaccination is a preventative immunization indicated for the induction of active immunity against infection by the measles (rubeola) paramyxovirus, mumps rubulavirus, and rubella togavirus These targeted viral pathogens cause acute systemic infections marked by respiratory spread, high fever, maculopapular rash, and parotitis Vaccination prevents severe pathophysiologic complications associated with these diseases, such as viral pneumonia, encephalitis, aseptic meningitis, ...
- cdc.gov
These targeted viral pathogens cause acute systemic infections marked by respiratory spread, high fever, maculopapular rash, and parotitis Vaccination prevents severe pathophysiologic complications associated with these diseases, such as viral pneumonia, encephalitis, aseptic meningitis, orchitis, and congenital rubella syndrome resulting from gestational transmission
- merckmanuals.com
Vaccination prevents severe pathophysiologic complications associated with these diseases, such as viral pneumonia, encephalitis, aseptic meningitis, orchitis, and congenital rubella syndrome resulting from gestational transmission
- cdc.gov
Vaccination prevents severe pathophysiologic complications associated with these diseases, such as viral pneumonia, encephalitis, aseptic meningitis, orchitis, and congenital rubella syndrome resulting from gestational transmission
Personalize your experience
Follow Measles-mumps-rubella vaccination and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.